A synthetic peptide for use as a blocking control in assays to test for specificity of ChGn antibody, Alternative Names: CHGN control peptide, CHGN antibody Blocking Peptide, Anti-CHGN Blocking Peptide, FLJ11264 Blocking Peptide, beta4GalNAcT Blocking Peptide
ChGn transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). This protein is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. It play an important role in chondroitin chain biosynthesis in cartilage.